Pembrolizumab: Hypophysitis and isolated ACTH deficiency.

Předmět:	ADRENOCORTICOTROPIC hormone PEMBROLIZUMAB BREAST cancer TREATMENT duration CONGENITAL disorders
Zdroj:	Reactions Weekly; Dec2023, Vol. 1985 Issue 1, p423-423, 1p
Abstrakt:	Author InformationAn event is serious (based on the ICH definition) when the patient outcome is:• * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important eventA 36-year-old woman developed hypophysitis and isolated ACTH deficiency following treatment with pembrolizumab for breast cancer [route, dosage and duration of treatment to reaction onsets not stated]. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink